Aker BioMarine ASA · OSL:AKBM
Aker BioMarine ASA — Q3 2009 Earnings Presentation
15 slides from Aker BioMarine ASA's earnings presentation, 2009
Slide 1: Accelerating growth for Superba Krill
Aker BioMarine Accelerating growth for Superba™ Krill Q3 2009 Hallvard Muri, CEO Fredrik Dokk Nygaard, CFO Matts Johansen, EVP Sales & Marketing The preferred partner part of Aker © Aker | Aker BioMarine 1
Slide 2: Highlights Q3 2009
Aker BioMarine Highlights Q3 2009 Upstream Season ended mid July, total harvest for the year 43.000 MT compared to 54.000 MT in 2008 QrillTM sales all time high, 2.700 MT compared to 1.200 MT in Q3 2008 Prices YTD 2009 somewhat weaker than same period 2008, but last few months solid recovery m
Slide 3: Key performance indicators
Aker BioMarine Key performance indicators Last five quarters (Q3/08 – Q3/09) Revenues* Operating cash flow* QrillTM feed sold Superba™ Krill sold NOKm NOKm MT MT 45 0 3 000 18 40 -20 16 2 500 35 14 -40 30 2 000 12 25 -60 10 1 500 20 -80 8 15 1 000 6 -100 10 4 -120 500 5 2 0 -140 0 0 Q3 Q4 Q1 Q2 Q3 Q
Slide 4: Income statement
Q3 2009 Income statement INCOME STATEMENT Continued revenue Actual Actual Actual Actual YTD Actual YTD Year Amounts in NOK million growth from increased Q2 2009 Q3 2009 Q3 2008 Q3-09 Q3-08 2008 sales of Superba™Krill Operating revenues 34 41 21 95 68 85 and Qrill™ Inventory change 11 (16) 16 8 43
Slide 5: Balance sheet and cash flow
Q3 2009 Balance sheet and cash flow Balance sheet Q2/09 Q3/09 Q3/08 YE 2008 Total assets 1,691 1,678 2,339 1,924 Total equity 371 305 774 500 Net interest bearing debt 747 775 1392 471 Equity % (including convertible debt) 45% 42% 49% 45% Cash flow Q2/09 Q3/09 Q3/08* YE 2008* Cash flow from operatin
Slide 6: Sales and marketing update
Sales and marketing update 1 US Bulk sales gaining momentum, well established and promising relationship with Schiff, Mercola just starting, and several mature cases in the pipeline. 2 Increasing activity in EU bulk sales, still low MT volumes, but increasing number of clients looks promising for No
Slide 7: In Q3, Aker BioMarine sold more than 30 million Superba Krill capsules in the US
In Q3, Aker BioMarine sold more than 30 million Superba™ Krill capsules in the US Revenues • The Schiff relationship is strong with good 20 Schiff and volumes and a productive cooperation 15 Mercola • Mercola.com contract just signed relationship 10 • Several interesting cases coming up 13,2 strong
Slide 8: The omega-3 market has grown tremendously
The omega-3 market has grown tremendously Omega-3 market has grown consistently… …but there is still room for more 2003-2008, US retail value in USD million 2008, US retail supplement value in USD million 18,150 724 Vitamins 7,544 +32% 603 470 349 256 Herbs 3,294 178 Omega-3 724 2003 2004 2005 2006
Slide 9: About Schiff Nutrition
About Schiff Nutrition Schiff’s Superba™ Krill product Fact sheet Schiff Nutrition International Listed on Nasdaq Develops, manufactures, markets and distributes vitamins, nutritional supplements and nutrition bars in the United States and throughout the world Top two brands in portfolio: Me
Slide 10: The preferred partner part of Aker © Aker | Aker BioMarine
The preferred partner part of Aker © Aker | Aker BioMarine 10
Slide 11: About Mercola
About Mercola Mercola’s Superba™ Krill product Fact sheet Mercola.com, one of the worlds most visited natural health site Founded and run by Dr. Mercola, a New York Times Best Selling Author with several US nation wide media appearances 1.500.000 subscribers to weekly newsletter One of the k
Slide 12: The preferred partner part of Aker © Aker | Aker BioMarine
The preferred partner part of Aker © Aker | Aker BioMarine 12
Slide 13: European sales hampered by the pending Novel Food approval
European sales hampered by the pending Novel Food approval Revenues • Currently, only access to small 4 Novel Food players/launches – Novel Food approval will 3 the key to open up market to larger players 2 3,6 open up the • Limited Competitor business to grab 1 2 market • Need to create market, foc
Slide 14: The omega-3 market in Europe is material, but lagging behind US in growth
The omega-3 market in Europe is material, but lagging behind US in growth… …but compared to US it is still Omega-3 market in Europe is material… room for more 2008, retail value in USD million 2008 omega-3 Revenues, million USD 300 16,00 % 800 600 250 12,00 % 724 400 200 573 200 150 8,00 % 0 100 US
Slide 15: The preferred partner part of Aker © Aker | Aker BioMarine
The preferred partner part of Aker © Aker | Aker BioMarine 15